GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kancera AB (OSTO:KAN) » Definitions » 12-1 Month Momentum %

Kancera AB (OSTO:KAN) 12-1 Month Momentum % : -48.11% (As of May. 04, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Kancera AB 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-04), Kancera AB's 12-1 Month Momentum % is -48.11%.

The industry rank for Kancera AB's 12-1 Month Momentum % or its related term are showing as below:

OSTO:KAN's 12-1 Month Momentum % is ranked worse than
73.62% of 1482 companies
in the Biotechnology industry
Industry Median: -21.305 vs OSTO:KAN: -48.11

Competitive Comparison of Kancera AB's 12-1 Month Momentum %

For the Biotechnology subindustry, Kancera AB's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kancera AB's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kancera AB's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Kancera AB's 12-1 Month Momentum % falls into.



Kancera AB  (OSTO:KAN) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kancera AB  (OSTO:KAN) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Kancera AB 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Kancera AB's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kancera AB (OSTO:KAN) Business Description

Traded in Other Exchanges
Address
Karolinska Institutet Science Park, Banvaktsvagen 22, Solna, SWE, 171 48
Kancera AB develops drugs that counteract damage in acute and chronic inflammation. The fractalkin blockers KAND567 and KAND145 are developed to effectively counteract hyperinflamation in various disease states and thereby protect vital organs in conjunction with myocardial infarction and severe viral infections. Kancera is planning two phase II clinical trials, in covid-19 and in cardiac patients. The company conducts research and development within the Karolinska Institute Science Park in Stockholm.

Kancera AB (OSTO:KAN) Headlines

No Headlines